Welcome address on the plenary stage in room Montreal at the Swiss Biotech Day 2026

ProgramPlenary sessions

Plenary sessions

Keynotes, fireside sessions and the Swiss Biotech Report.

When
Day one, 12:30 to 14:00, and day two, 10:00 to 12:00
Where
Room Montreal, level 2
Format
Welcome addresses, fireside sessions, keynote and investor panels, report launch and award
Who speaks
The host canton, the Swiss Biotech Association, CEOs of global pharma and biotech, investors, regulators
Access
Included in the conference pass; the plenary is the one session everyone attends

About the format

Two plenary sessions frame the conference: the opening plenary on the first afternoon and the second plenary on the morning of day two, where the Swiss Biotech Report is launched and the Swiss Biotech Success Stories Award is presented.

The opening plenary sets the theme of the year. In 2026, Kaspar Sutter welcomed the conference on behalf of the Canton of Basel-Stadt, Michael Altorfer opened for the Swiss Biotech Association, and Roche CEO Thomas Schinecker joined Swiss Biotech Association President Patrick Amstutz for a fireside session, followed by a business development panel and Swissmedic.

The second plenary belongs to the ecosystem: a keynote panel on the state of Swiss biotech, the launch of the Swiss Biotech Report with EY, the Swiss Biotech Success Stories Award and an investor panel with cross-Atlantic perspectives on Swiss biotech.

Two speakers in armchairs on the plenary stage during the fireside session
Fireside session on the plenary stage in room Montreal at the Swiss Biotech Day 2026.

Why take part

What plenary sessions offer

  1. The year's theme, on stage

    Fireside sessions with the leaders shaping the Swiss and global industry.

  2. Swiss Biotech Report launch

    The definitive annual review of the Swiss biotech industry, presented live.

  3. Success Stories Award

    The Swiss Biotech Association honors a career of sustainable contribution to the industry.

Last edition

Plenary program 2026

Both plenaries were moderated by Monika Jones.

See the full 2026 plenary program
  • Monday, 12:45

    Fireside session: Thomas Schinecker, CEO Roche Group, with Patrick Amstutz

    Plenary I

  • Monday, 13:20

    Business development panel with Cooley, Centerview, BeOne Medicines and Araris

    Plenary I

  • Monday, 13:45

    Swissmedic: Vincenza Trivigno, Executive Director

    Plenary I

  • Tuesday, 10:10

    Keynote panel on the Swiss biotech ecosystem with Versant Ventures, Windward Bio, Roche pRED and Omega Ventures

    Plenary II

  • Tuesday, 10:55

    Swiss Biotech Report 2026 with EY

    Plenary II

  • Tuesday, 11:25

    Investor panel: cross-Atlantic perspectives with Bain Capital, Vianti Capital and Novo Ventures

    Plenary II

Be in the room on April 26 and 27, 2027

The plenary sessions are not streamed or recorded. Register to attend in person.